Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin for Hypertriglyceridemia Pancreatitis
NCT03501680Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jun 2018
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of human insulin in hypertriglyceridemia-induced acute pancreatitis (HTGP), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Status: unknown.
02
Drugs
human insulin
03
Conditions
hypertriglyceridemia-induced acute pancreatitis (HTGP)
Beyond the preview
Go deeper on NCT03501680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03501680.